Basiliximab Maintenance in Ulcerative Colitis

NCT01061996 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

88

Enrollment

INDUSTRY

Sponsor class

Stopped lack of efficacy

Conditions

Ulcerative Colitis

Interventions

DRUG: Basiliximab

Sponsor

Cerimon Pharmaceuticals